Pasar al contenido principal

Joan Sahuquillo Barris

Instituciones de las que forman parte

Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN)
Vall Hebron Institut de Recerca

Líneas de investigación

Neuro-oncology (Emerging line)

In this new line of translational research, we collaborate actively with the Vall d'Hebron Institute of Oncology (VHIO) lead by Dr. J. Baselga and especially with the "Gene Expression and Cancer" laboratory led by Dr. J. Seoane.


Aims: 1) To develop a patient registry, centralized in external servers, to study the epidemiology, diagnosis and treatment results of primary and secondary brain tumors (Gliomas and metastases); 2) To develop a methodology for studying quality of life and cost-effectiveness of surgery and certain treatments in patients with malignant CNS tumors;

3) To study the cost-effectiveness of cortical mapping in low-grade tumors removed by awake craniotomy; 4) To develop cell lines of glioma primary cultures and glioma stem cells for improving knowledge of route regulation at all levels, especially pre- and-post-transcriptional; and 5) To study potential therapeutic targets derived from knowledge of the factors involved in the regulation of neuro-oncogenesis in glial cell tumors.


IP: Joan Sahuquillo Barris, Francisco Ramón Martínez Ricarte

Neurotraumatology (Consolidated Line)

General aims: To study alterations in brain metabolism, neurochemical alterations, pathophysiology, and new monitoring techniques and treatments in traumatic brain injury (TBI) and in neurocritical patients.


Specific aims: 1) To increase knowledge of tissular metabolic and O2 transport alterations in acute brain lesions; 2) To study cerebral and systemic neuro-inflammatory response through high resolution microdialysis techniques; 3) To analyze  peri-infarct depolarization phenomena in patients with acute brain injury (COSBID European study); 4) To apply of high-resolution microdialysis to define the molecular profile of post-traumatic brain edema and the contribution of non-selective cationic channels to its formation; and 5) To study mitochondrial dysfunction after traumatic brain injury (TBI) in patients and in histotóxica hypoxia can be modeled and reproduced in adult human brain slices obtained from surgically extracted specimens.

IP: Joan Sahuquillo Barris

Hydrocephalus and alterations in the dynamics of cerebrospinal fluid (CSF) (Consolidated Line)

General aim: To study the pathophysiology of intracranial pressure (ICP) and alterations in CSF dynamics in patients with hydrocephalus and other intracranial pathologies.


Specific aims: 1) To gain greater insight into the physiopathology of normal pressure hydrocephalus and idiopathic intracranial hypertension (pseudotumor cerebri) and to study new diagnostic and therapeutic strategies; 2) To determine the biochemical alterations (neurotransmitters and neuropeptides) in these patients, as well as their role in cognitive function and sleep disturbances; and 3) To correlate cognitive deficit with morphological and functional alterations in different cerebral structures, such as the corpus callosum and subcortical white matter.


IP: Ma Antonia Poca Pastor, Joan Sahuquillo Barris

Malignant Middle Cerebral Artery Infarction (MMCAI) (Consolidated Line)

General aim: To expand on the physiopathology, metabolic alterations, and monitoring of patients with malignant MCA infarction.


Specific aims: 1) To gain greater insight into the physiopathology, metabolic alterations, and monitoring of patients with malignant middle cerebral artery infarction; 2) To optimize treatment through the use of novel techniques, such as moderate hypothermia and decompressive craniectomy;  3) To characterize the inflammatory response profile (cerebral and systemic) triggered by massive ischemic stroke; 4) To optimize the treatment of severe head injury and MMCAI using new therapeutic techniques such as the combination of moderate hypothermia and decompressive craniotomy, and 5) To study and evaluate the quality of life of patients who survive a malignant middle cerebral artery infarction (MMCAI).

IP: Joan Sahuquillo Barris, José Alvarez Sabin

Proyectos

ADQUISICIÓN DE UN MICROSCOPIO MULTIDIMENSIONAL WIDEFIELD EQUIPADO PARA REALIZAR EXPERIMENTOS IN VIVO, DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT)

IP: Inmaculada Fuentes Camps
Colaboradores: Maria Vicario Perez, Soledad Gallego Melcón, Fco Javier Santos Vicente, Diego Arango Corro, Gema Ariceta Iraola, Santiago Ramon y Cajal Agüeras, Marta Martínez Vicente, Anna Meseguer Navarro, Manuel Comabella Lopez, Ricardo Pujol Borrell, Joan Sahuquillo Barris, Joan Xavier Comella Carnicé, Miguel Segura Ginard, Simon Schwartz Navarro, Anna Rosell Novel, Meritxell Genesca Ferrer
Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN
Financiación: 177204.2
Referencia: EQC2019-006309-P
Duración: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

Study of the Tumor Microenvironment in Brain Cancer / Estudio del microambiente tumoral en el cáncer de cerebro

IP: Joan Sahuquillo Barris
Colaboradores: -
Entidad financiadora:
Financiación:
Referencia: PR(AG)200/2019
Duración: -

Estudio de los tumores cerebrales (glioblastoma y metástasis) para la identificación de mejores tratamientos y desarrollo de métodos de diagnóstico molecular no invasivo

IP: Joan Sahuquillo Barris
Colaboradores: -
Entidad financiadora: Asociación Española Contra el Cáncer
Financiación:
Referencia: AECC/2017/TRASLACIONAL--DUPLICAT
Duración: 06/02/2018 - 06/02/2018

Anemia or Blood Transfusion: A Clinical Dilemma in patient with traumatic brain injury

IP: Ma Antonia Poca Pastor
Colaboradores: Dario Fabian Gándara Sabatini, Marylin Riveiro Vilaboa, Joan Sahuquillo Barris, Anna Rey Pérez, Miriam de Nadal Clanchet, Verónica Pons Escoll
Entidad financiadora: Fundació La Marató de TV3
Financiación: 191336.25
Referencia: 20172430
Duración: 27/06/2018 - 31/12/2021

Noticias relacionadas

Entre los proyectos se encuentran 12 investigaciones en las que participan investigadores e investigadoras de Vall d'Hebron.

Estos resultados suponen un avance no solo para la salud de los pacientes sino también para el sistema sanitario y la salud pública, disminuyendo drásticamente el número de transfusiones necesarias.

Profesionales relacionados

Ma Antonia Poca Pastor

Ma Antonia Poca Pastor

Jefe de grupo
Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN)
Leer más
Ignasi Maspons Molins

Ignasi Maspons Molins

Leer más
Ana Belén  Méndez Fernández

Ana Belén Méndez Fernández

Investigador postdoctoral
Leer más
Paula Schartzman Goldwaser

Paula Schartzman Goldwaser

Leer más

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

Vall d'Hebron Barcelona Hospital Campus es un parque de referencia mundial donde la asistencia, la investigación, la docencia y la innovación se dan la mano.